22-50077379-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_015166.4(MLC1):c.525+22G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.145 in 1,602,054 control chromosomes in the GnomAD database, including 17,733 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.14 ( 1735 hom., cov: 33)
Exomes 𝑓: 0.14 ( 15998 hom. )
Consequence
MLC1
NM_015166.4 intron
NM_015166.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.03
Publications
4 publications found
Genes affected
MLC1 (HGNC:17082): (modulator of VRAC current 1) The function of this gene product is unknown; however, homology to other proteins suggests that it may be an integral membrane transporter. Mutations in this gene have been associated with megalencephalic leukoencephalopathy with subcortical cysts, an autosomal recessive neurological disorder. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
MLC1 Gene-Disease associations (from GenCC):
- megalencephalic leukoencephalopathy with subcortical cysts 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Myriad Women’s Health
- megalencephalic leukoencephalopathy with subcortical cystsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 22-50077379-C-T is Benign according to our data. Variant chr22-50077379-C-T is described in ClinVar as Benign. ClinVar VariationId is 260574.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.207 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MLC1 | NM_015166.4 | c.525+22G>A | intron_variant | Intron 6 of 11 | ENST00000311597.10 | NP_055981.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MLC1 | ENST00000311597.10 | c.525+22G>A | intron_variant | Intron 6 of 11 | 1 | NM_015166.4 | ENSP00000310375.6 | |||
| MLC1 | ENST00000395876.6 | c.525+22G>A | intron_variant | Intron 6 of 11 | 1 | ENSP00000379216.2 | ||||
| MLC1 | ENST00000442311.1 | c.435+22G>A | intron_variant | Intron 5 of 7 | 5 | ENSP00000401385.1 |
Frequencies
GnomAD3 genomes AF: 0.143 AC: 21757AN: 152114Hom.: 1719 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
21757
AN:
152114
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.167 AC: 41386AN: 247908 AF XY: 0.163 show subpopulations
GnomAD2 exomes
AF:
AC:
41386
AN:
247908
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.145 AC: 209850AN: 1449822Hom.: 15998 Cov.: 30 AF XY: 0.145 AC XY: 104432AN XY: 721788 show subpopulations
GnomAD4 exome
AF:
AC:
209850
AN:
1449822
Hom.:
Cov.:
30
AF XY:
AC XY:
104432
AN XY:
721788
show subpopulations
African (AFR)
AF:
AC:
3796
AN:
33244
American (AMR)
AF:
AC:
12685
AN:
44504
Ashkenazi Jewish (ASJ)
AF:
AC:
4671
AN:
26054
East Asian (EAS)
AF:
AC:
7971
AN:
39616
South Asian (SAS)
AF:
AC:
12702
AN:
85750
European-Finnish (FIN)
AF:
AC:
6414
AN:
52894
Middle Eastern (MID)
AF:
AC:
846
AN:
5712
European-Non Finnish (NFE)
AF:
AC:
152034
AN:
1102068
Other (OTH)
AF:
AC:
8731
AN:
59980
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
9575
19150
28724
38299
47874
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
5576
11152
16728
22304
27880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.143 AC: 21793AN: 152232Hom.: 1735 Cov.: 33 AF XY: 0.143 AC XY: 10672AN XY: 74440 show subpopulations
GnomAD4 genome
AF:
AC:
21793
AN:
152232
Hom.:
Cov.:
33
AF XY:
AC XY:
10672
AN XY:
74440
show subpopulations
African (AFR)
AF:
AC:
4635
AN:
41544
American (AMR)
AF:
AC:
3261
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
679
AN:
3470
East Asian (EAS)
AF:
AC:
1021
AN:
5172
South Asian (SAS)
AF:
AC:
727
AN:
4818
European-Finnish (FIN)
AF:
AC:
1220
AN:
10622
Middle Eastern (MID)
AF:
AC:
35
AN:
294
European-Non Finnish (NFE)
AF:
AC:
9694
AN:
67990
Other (OTH)
AF:
AC:
345
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
958
1915
2873
3830
4788
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
244
488
732
976
1220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
635
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Megalencephalic leukoencephalopathy with subcortical cysts 1 Benign:1
Jun 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.